Human mesenchymal stem cells improve the neurodegeneration of femoral nerve in a diabetic foot ulceration rats

Neuroscience Letters

Volumn 597, Issue , 2015, Pages 84-89

  Xia, Nan ^a   Xu, Jin Mei ^a   Zhao, Nan ^a   Zhao, Qing Song ^a   Li, Ming ^a   Cheng, Zhi Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic foot; Electroneurogram; Human mesenchymal stem cells from umbilical cord matrix; Neurofilament; NGF; Peripheral neuropathy

Indexed keywords

NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN H;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETIC FOOT; ELECTRON MICROSCOPY; ELECTRONEUROGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; FEMORAL NERVE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROSCOPY; MUSCLE CELL; MUSCLE INNERVATION; NERVE CELL DEGENERATION; NERVE CONDUCTION; NERVE DEGENERATION; NERVE FIBER; NERVE FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; INNERVATION; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC FOOT; FEMORAL NERVE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE DEGENERATION; NERVE GROWTH FACTOR; NEURAL CONDUCTION; NEUROFILAMENT PROTEINS; NEURONS; RATS, SPRAGUE-DAWLEY;

EID: 84929660282     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.04.038     Document Type: Article

References (29)

1. Dulipsingh L., Zailskas S., Goldsby T., McInnis T., Marotta A. Assessment of pain and treatment satisfaction in patients with painful diabetic peripheral neuropathy. Conn. Med. 2013, 77(9):523-527.
2. Boulton A.J., Malik R.A., Arezzo J.C., Sosenko J.M. Diabetic somatic neuropathies. Diabetes Care 2004, 27(6):1458-1486.
3. Kennedy J.M., Zochodne D.W. Impaired peripheral nerve regeneration in diabetes mellitus. J. Peripher. Nerv. Syst. 2005, 10(2):144-157.
4. Ishimine H., Yamakawa N., Sasao M., Tadokoro M., Kami D., Komazaki S., et al. N-Cadherin is a prospective cell surface marker of human mesenchymal stem cells that have high ability for cardiomyocyte differentiation. Biochem. Biophys. Res. Commun. 2013, 438(4):753-759.
5. Marmotti A., Mattia S., Bruzzone M., Buttiglieri S., Risso A., Bonasia D.E., et al. Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. Stem Cells Int. 2012, 2012:326813.
6. Borghesi A., Avanzini M.A., Novara F., Mantelli M., Lenta E., Achille V., et al. Genomic alterations in human umbilical cord-derived mesenchymal stromal cells call for stringent quality control before any possible therapeutic approach. Cytotherapy 2013, 15(11):1362-1373.
7. Zhao Q.S., Xia N., Zhao N., Li M., Bi C.L., Zhu Q., et al. Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats. Int. J. Biol. Sci. 2013, 10(1):80-89.
8. Alavi A., Sibbald R.G., Mayer D., Goodman L., Botros M., Armstrong D.G., et al. Diabetic foot ulcers: part I. Pathophysiology and prevention. J. Am. Acad. Dermatol. 2014, 70(1):1e-18. quiz 9-20.
9. Reed M.J., Meszaros K., Entes L.J., Claypool M.D., Pinkett J.G., Gadbois T.M., et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49(11):1390-1394.
10. Yang W., Lu J., Weng J., Jia W., Ji L., Xiao J., et al. Prevalence of diabetes among men and women in China. New Engl. J. Med. 2010, 362(12):1090-1101.
11. Cavanagh P., Attinger C., Abbas Z., Bal A., Rojas N., Xu Z.R. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab. Res. Rev. 2012, 28(Suppl. 1):107-111.
12. Li B.Y., Qiao G.F., Feng B., Zhao R.B., Lu Y.J., Schild J.H. Electrophysiological and neuroanatomical evidence of sexual dimorphism in aortic baroreceptor and vagal afferents in rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295(4):R1301-10.
13. Santa Cruz Chavez G.C., Li B.Y., Glazebrook P.A., Kunze D.L., Schild J.H. An afferent explanation for sexual dimorphism in the aortic baroreflex of rat. Am. J. Physiol. Heart Circ. Physiol. 2014, 307(6):H910-21.
14. Lohrke S., Brandstatter J.H., Boycott B.B., Peichl L. Expression of neurofilament proteins by horizontal cells in the rabbit retina varies with retinal location. J. Neurocytol. 1995, 24(4):283-300.
15. Fernyhough P., Schmidt R.E. Neurofilaments in diabetic neuropathy. Int. Rev. Neurobiol. 2002, 50:115-144.
16. Lee H.J., Bach J.R., DeLisa J.A. Medial femoral cutaneous nerve conduction. Am. J. Phys. Med. Rehabil. 1995, 74(4):305-307.
17. Young M.J., Veves A., Smith J.V., Walker M.G., Boulton A.J. Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia 1995, 38(9):1051-1054.
18. Jelicic Kadic A., Boric M., Kostic S., Sapunar D., Puljak L. The effects of intraganglionic injection of calcium/calmodulin-dependent protein kinase II inhibitors on pain-related behavior in diabetic neuropathy. Neuroscience 2014, 256:302-308.
19. Kestendjieva S., Kyurkchiev D., Tsvetkova G., Mehandjiev T., Dimitrov A., Nikolov A., et al. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol. Int. 2008, 32(7):724-732.
20. Fiore M., Chaldakov G.N., Aloe L. Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems. Rev. Neurosci. 2009, 20(2):133-145.
21. Gezginci-Oktayoglu S., Karatug A., Bolkent S. The relation among NGF-EGF and insulin is important for triggering pancreatic beta cell apoptosis. Diabetes Metabol. Res. Rev. 2012, 28(8):654-662.
22. Madduri S., Papaloizos M., Gander B. Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res. 2009, 65(1):88-97.
23. Allard S., Leon W.C., Pakavathkumar P., Bruno M.A., Ribeiro-da-Silva A., Cuello A.C. Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype. J. Neurosci. 2012, 32(6):2002-2012.
24. Peplow P.V., Baxter G.D. Gene expression and release of growth factors during delayed wound healing: a review of studies in diabetic animals and possible combined laser phototherapy and growth factor treatment to enhance healing. Photomed. Laser Surg. 2012, 30(11):617-636.
25. Lu X.L., Xu W.X., Yan Z.Y., Qian Z., Xu B., Liu Y., et al. Subtype identification in acutely dissociated rat nodose ganglion neurons based on morphologic parameters. Int. J. Biol. Sci. 2013, 9(7):716-727.
26. Zochodne D.W., Sun H.S., Cheng C., Eyer J. Accelerated diabetic neuropathy in axons without neurofilaments. Brain 2004, 127(Pt 10):2193-2200.
27. Naruse K., Hamada Y., Nakashima E., Kato K., Mizubayashi R., Kamiya H., et al. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 2005, 54(6):1823-1828.
28. Shibata T., Naruse K., Kamiya H., Kozakae M., Kondo M., Yasuda Y., et al. Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 2008, 57(11):3099-3107.
29. Inoue H., Murakami T., Ajiki T., Hara M., Hoshino Y., Kobayashi E. Bioimaging assessment and effect of skin wound healing using bone-marrow-derived mesenchymal stromal cells with the artificial dermis in diabetic rats. J. Biomed. Opt. 2008, 13(6):064036.